These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22799032)

  • 21. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
    Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
    J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of hyphenated LC-MS technique for characterisation of impurity profiles during drug development.
    Ermer J
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):707-14. PubMed ID: 9919972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of high-performance liquid chromatography hyphenated techniques for identification of degradation products of cefpodoxime proxetil.
    Fukutsu N; Kawasaki T; Saito K; Nakazawa H
    J Chromatogr A; 2006 Oct; 1129(2):153-9. PubMed ID: 16846608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation and structural characterization of unknown impurity in vancomycin by two-dimensional preparative liquid chromatography, LC-MS and NMR.
    Wang X; Qiu Y; Wen H; Weng R; Chen D; Liu H
    J Pharm Biomed Anal; 2023 Aug; 232():115403. PubMed ID: 37120972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impurity profiling of N,N'-ethylenebis-l-cysteine diethyl ester (Bicisate).
    Wahl O; Cleynhens J; Verbruggen AM; Holzgrabe U
    J Pharm Biomed Anal; 2018 Feb; 150():132-136. PubMed ID: 29223061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of the impurity in auramine O by high performance liquid chromatography-ion trap-time of flight mass spectrometry and preparation of the auramine O reference standard by preparative high performance liquid chromatography].
    Che F; Lu Y; Xi X; Lan T; Wei Y
    Se Pu; 2019 Mar; 37(3):299-304. PubMed ID: 30900859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyphenated liquid chromatography - diode array detection - charged aerosol detection - high resolution - multistage mass spectrometry with online hydrogen/deuterium exchange: One stop solution for pharmaceutical impurity profiling.
    Thakkar H; Jain S; Kumar S; Bhalekar VS; Gangakhedkar S; Shah RP
    J Chromatogr A; 2023 Jan; 1689():463725. PubMed ID: 36586282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation, structural elucidation and characterization of impurities in Cefdinir.
    Rao KV; Rani A; Reddy AV; Bharathi CH; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Mar; 43(4):1476-82. PubMed ID: 17174507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of LC detection methods in the investigation of non-UV detectable organic impurities in a drug substance.
    McCrossen SD; Bryant DK; Cook BR; Richards JJ
    J Pharm Biomed Anal; 1998 Jul; 17(3):455-71. PubMed ID: 9656157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a trace colored impurity in drug substance by preparative liquid chromatography and mass spectrometry.
    Wang P; Shi YJ; Helmy R; Reamer R; Vailaya A
    Rapid Commun Mass Spectrom; 2005; 19(24):3749-54. PubMed ID: 16308847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
    Wu CS; Tong YF; Wang PY; Wang DM; Wu S; Zhang JL
    Rapid Commun Mass Spectrom; 2013 May; 27(9):971-8. PubMed ID: 23592199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation and characterization of unknown impurities in rutin tablets using trap-free two-dimensional liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Ren X; Wen C; Xu Y; Chen Y
    Rapid Commun Mass Spectrom; 2020 May; 34(10):e8739. PubMed ID: 31986235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple heart-cutting two dimensional liquid chromatography mass spectrometry: Towards real time determination of related impurities of bio-pharmaceuticals in salt based separation methods.
    Petersson P; Haselmann K; Buckenmaier S
    J Chromatogr A; 2016 Oct; 1468():95-101. PubMed ID: 27667648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.